Patent · US Active

Crystalline forms of bosentan

US8530488B2 · kind B2 · utility

0Cited by
5References
28Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 24, 2008
Grant dateSep 10, 2013
Priority date
Expiry dateDec 17, 2028

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P11/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to novel crystalline forms of bosentan and processes for their preparation. Further, the invention relates to pharmaceutical compositions comprising said crystalline forms and use of said compositions in the treatment of patients suffering from endothelin receptor mediated disorders, for example, cardiovascular disorders such as hypertension, pulmonary hypertension, ischemia, vasospasm and angina pectoris.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.